Empowering Black male caregivers to support Black girls' sexual health
Official title: A Family-Based HIV Prevention Program for Black Men to Protect Black Girls
Run by University of Illinois Chicago · NCT06266416 · Data updated 2026-11-12
This study tests a new program that helps Black male caregivers support Black girls in staying healthy and safe from STIs and sexual violence.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 13 Years and up |
| Sex | All |
| Enrollment | 612 (estimated) |
| Sponsor | University of Illinois Chicago Academic / other |
| Locations | 1 site (Chicago, Illinois) |
| Status | Recruiting |
| Started | September 2, 2024 |
| Main results expected | July 30, 2027 |
| Study ends | May 31, 2028 |
| Registry record updated | April 17, 2026 |
| Trial ID | NCT06266416 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are Black male caregivers of girls aged 14-19 who self-identify as African American or Black.
✕Probably not a fit
Patients who may not benefit from this study include those who do not have a male caregiver involved in their lives or those who do not meet the racial and language criteria.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to improve sexual reproductive health outcomes for Black girls by engaging Black male caregivers in prevention programs for sexually transmitted infections (STIs) and HIV. It recognizes the significant impact of familial relationships on the health of Black girls, particularly in addressing risks related to STIs and sexual violence. The intervention adapts an existing program, IMARA, to include male caregivers, thereby enhancing protective factors through family involvement. The study will assess the effectiveness of this adapted program in a community-based setting.
Why it matters
Potential benefit: If successful, this intervention could significantly reduce the rates of STIs and HIV among Black girls by leveraging the support of male caregivers.
How similar studies have gone: Other studies have shown success in engaging family members in health interventions, but this specific approach of including male caregivers is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: AIM 1: * Self-identify as African American, Black, or mixed race with African American or Black * Speak English * Males must identify as a current caregiver to girl enrolled in the study AIM 2: All Community Based Organizations (CBO) directors and IMAGE liaisons will be eligible. Exclusion Criteria: AIM 1: * Girl refuses to participate * Inability to understand the consent/assent process * Non-English speaking * Does not self-identify as African American, Black, or mixed race with African American or Black * If the primary caregiver (female caregiver/mother) does not consent to the girls' participation with the male caregiver the girl chooses, the girl will not be able to participate * Girls will be excluded if they participated in other phases of the research AIM 2: • Inability to understand the consent process, and non-employment at a partnering CBO.
Where it's running
-
University of Illinois Chicago
Chicago, Illinois, United States Recruiting
Study contacts
- Study coordinator: Natasha Crooks, PhD
- Email: ncrooks@uic.edu
- Phone: 312-996-5801
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Exploring HIV risk in vulnerable youth with digital health intervention
This study is trying to see how a digital health program can help young sexual and gender minorities reduce their risk of HIV and understand the factors that affect their prevention choices.
-
Camino HIV Prevention and Care Study
This study tests a combined legal and peer-support program to help Latin American adults in DC and the Bay Area improve HIV testing, PrEP use, and care engagement.
-
VH4367310 in healthy adults: testing single increasing doses for safety and how it behaves in the body
This study tests a single rising dose of VH4367310, a cabotegravir prodrug, to see how it behaves in the body and how safe and tolerable it is in healthy adults aged 18 to 55.
-
Online cohort of sexual and gender minorities testing digital support to boost PrEP and ART use
In Brazil, sexually and gender diverse adults are being followed online to see if weekly WhatsApp reminders help people stick to PrEP or ART.
-
Sexual Health in Spanish-Speaking Adults: A Large Online Survey
A large online survey will test sexual health, sexual behavior, and sexual function in Spanish-speaking adults to see how common these experiences are and to explore unusual states of consciousness during orgasm.
-
Metabolic Liver Disease in People Newly Diagnosed with HIV
This study tests whether HIV-infected adults who are starting ART are more likely to develop MASLD and related liver issues than HIV-negative adults over five years.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.